Isatuximab monotherapy or combination therapy with dexamethasone in older adult patients with relapsed/refractory multiple myeloma: a single institution experience

被引：0
|
作者：
Iino, Masaki [1 ]
Mikawa, Takahiro [1 ]
Kido, Shinji [1 ]
Fujimori, Ken [1 ]
机构：
[1] Yamanashi Prefectural Cent Hosp, Yamanashi, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-273
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [31] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [32] Prophylactic Dexamethasone and Remote Monitoring for Patients with Relapsed Refractory Multiple Myeloma (RRMM) Receiving Bispecific Antibodies (BsAb): Experience at a Single Institution
    Varga, Cindy
    Ahmed, Ferdous
    Knight, Marvin
    Bhutani, Manisha
    Paul, Barry
    Atrash, Shebli
    Voorhees, Peter M.
    Ferreri, Christopher
    BLOOD, 2024, 144 : 4720 - 4721
  • [33] Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience
    Tommaso Caravita
    Agostina Siniscalchi
    Andrea Tendas
    Luca Cupelli
    Micaela Ales
    Alessio Perrotti
    Pasquale Niscola
    Paolo de Fabritiis
    Annals of Hematology, 2011, 90 : 115 - 116
  • [34] Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience
    Caravita, Tommaso
    Siniscalchi, Agostina
    Tendas, Andrea
    Cupelli, Luca
    Ales, Micaela
    Perrotti, Alessio
    Niscola, Pasquale
    de Fabritiis, Paolo
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 115 - 116
  • [35] ISATUXIMAB UPDATES FOR NURSES: ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA PATIENTS (IKEMA)
    Wilmoth, Jenal
    Marion, Sylvia
    Kellam, Christine
    ONCOLOGY NURSING FORUM, 2021, 48 (02)
  • [36] A SINGLE CENTER EXPERIENCE OF POMALIDOMIDE PLUS DEXAMETHASONE (PD) IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)
    Duran, M.
    Tombuloglu, M.
    Tobu, M.
    Vural, F.
    Sahin, F.
    Patir, P.
    Uysal, A.
    Saydam, G.
    LEUKEMIA RESEARCH, 2016, 49 : S18 - S19
  • [37] Our Experience of Using Lenalidomide, Bortezomib and Dexamethasone (RVD) Therapy in Patients with Relapsed/Refractory Multiple Myeloma
    Pogosyan, Gayane
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S340 - S341
  • [38] Outcomes of ide-cel in patients with relapsed/refractory multiple myeloma: A single-institution experience
    Trando, Aaron
    Ghamsari, Farid
    Yeung, Philip
    Costello, Caitlin
    Saunders, Ila M.
    Jeong, Ah-Reum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] DARATUMUMAB IN MONOTHERAPY AND COMBINATION AS TREATMENT IN RELAPSED / REFRACTORY MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL HOSPITAL
    Auria Caballero, C.
    Gamarro Calvo, S.
    De Poo Rodriguez, M., V
    Martinez Fernandez, R.
    Sanchez Quinones, B.
    Dourdil Sahun, M., V
    Bonafonte Arruga, E.
    Alcacera Lopez, A.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2018, 103 : 124 - 124
  • [40] Pomalidomide, Cyclophosphamide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Retrospective Single Center Experience
    Garderet, Laurent
    Polge, Emmanuelle
    Gueye, Mor Seny
    Kellil, Chaima
    Ova, Jeanny Guelongo Okouango
    Beohou, Eric
    Labopin, Myriam
    Mohty, Mohamad
    BLOOD, 2015, 126 (23)
12345